Multiple myeloma simulating olfactory sulcus meningioma: case report and review of the literature
DOI:
https://doi.org/10.59156/revista.v39i02.734Keywords:
Bicoronal approach, Olfactory sulcus meningioma, Multiple myeloma, Total resectionAbstract
Introduction: central nervous system involvement by multiple myeloma is extremely rare and is diagnosed in less than 1% of cases. Differential diagnosis should be made with lymphomas, metastases, sarcomas, osteochondromas, hemangiopericytomas, infectious meningitis or meningiomas.
Objective: to report an unusual case of a giant brain space occupying lesion simulating a meningioma of the olfactory sulcus.
Case description: 46-year-old female patient with a history of multiple myeloma in apparent remission after autologous bone marrow transplantation, who consulted for a palpable mass in the frontal region associated with holocranial headache of intensity 7/10 and decreased visual acuity of two months of evolution with imaging studies compatible with olfactory sulcus meningioma.
Intervention: craniotomy and total resection of the lesion by bicoronal approach. Histological sections showed a neoplastic proliferation consisting of cells with a spherical nucleus and lateralized eosinophilic cytoplasm. CD 138 +++ at membrane level. Lesion compatible with involvement of the central nervous system by multiple myeloma.
Conclusion: the unusual finding of this pathology offers challenges in the preoperative imaging diagnosis due to the great similarities with other neoplasms, mainly meningiomas, so it is important to consider it as a differential diagnosis.
Downloads
References
Abdallah A-ola, Atrash S, Shahid Z, Jameel M, Grazziutti M, Apewokin S, et al. Patterns of central nervous system involvement in relapsed and refractory multiple myeloma. Clin Lymphoma Myeloma Leuk, 2014; 14(3): 211-4.
Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol, 2014; 15(12): e538-48.
Bergantim R, Bastos J, Soares MJ, Carvalho B, Soares P, Marques C, et al. Aggressive central nervous system relapse after autologous stem cell transplant in multiple myeloma: case reports and literature review. Case Rep Hematol, 2020; 2020: 8563098.
Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, et al. Central nervous system involvement by multiple myeloma: A multi‐institutional retrospective study of 172 patients in daily clinical practice. Am J Hematol, 2016; 91(6): 575-80.
Sammartano V, Cerase A, Venanzi V, Mazzei MA, Vangone BE, Gentili F, et al. Central nervous system myeloma and unusual extramedullary localizations: real life practical guidance. Front Oncol, 2022; 12: 934240.
Chen CI, Masih‐Khan E, Jiang H, Rabea A, Cserti‐Gazdewich C, Jimenez‐Zepeda VH, et al. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents. Br J Haematol, 2013; 162(4): 483-8.
Cerase A, Tarantino A, Gozzetti A, Muccio CF, Gennari P, Monti L, et al. Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology, 2008; 50(8): 665-74.
Dias ALMS, Higashi F, Peres ALM, Cury P, Crusoé EDQ, Hungria VTDM. Multiple myeloma and central nervous system involvement: experience of a Brazilian center. Hematol Transfus Cell Ther, 2018; 40(1): 30-6.
Sahin F, Saydam G, Ertan Y, Calli C, Dönmez A, Tombuloglu M. Dural plasmacytoma mimicking meningioma in a patient with multiple myeloma. J Clin Neurosci, 2006; 13(2): 259-61.
Paludo J, Painuly U, Kumar S, Gonsalves WI, Rajkumar V, Buadi F, et al. Myelomatous involvement of the central nervous system. Clin Lymphoma Myeloma Leuk, 2016; 16(11): 644-54.
Bladé J, Beksac M, Caers J, Jurczyszyn A, Von Lilienfeld-Toal M, Moreau P, et al. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J, 2022; 12(3): 45.
Bhutani M, Foureau DM, Atrash S, Voorhees PM, Usmani SZ. Extramedullary multiple myeloma. Leukemia, 2020; 34(1): 1-20.
Na’ara S, Amit M, Gil Z, Billan S. Plasmacytoma of the skull base: a meta-analysis. J Neurol Surg B Skull Base, 2015; 77(01): 61-5.
Gozzetti A, Candi V, Papini G, Bocchia M. Therapeutic advancements in multiple myeloma. Front Oncol, 2014; 4(4): 241.
Katodritou E, Terpos E, Kastritis E, Delimpasis S, Symeonidis AS, Repousis P, et al. Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience. Ann Hematol, 2015; 94(12): 2033-42.
